WATERTOWN, Mass.--(BUSINESS WIRE)--pSivida Corp. (NASDAQ:PSDV)(ASX:PVA)(FF:PV3), a leading drug delivery company, today announced that seven abstracts describing its ophthalmic drug delivery products and technologies have been accepted by the Association for Research in Vision and Ophthalmology (ARVO) for presentation at the upcoming 2009 Annual Meeting to be held May 3-7 in Fort Lauderdale, Florida.
